← Back to Stem Cell / Exosome Treatment
Your concerns. A thoughtful conversation.

Pulmonary
A thoughtful conversation about breathing.

Begin with your respiratory diagnosis and your pulmonologist’s care plan. Review what is known before considering a product marketed for lung health.

Illustrative pulmonary clinician and patient reviewing a lung model in an elegant medical office
A thoughtful conversation about your breathing.
Explore lung health

Understand your concerns.
Make space for questions.

Bring your diagnosis, respiratory history, and current care plan to a conversation with your provider and pulmonary specialist.

01 / LUNG HEALTH

Asthma

Chronic inflammation and narrowing of the airways.

02 / LUNG HEALTH

Chronic Bronchitis

Long-term inflammation of the bronchial tubes, often with a persistent cough.

03 / LUNG HEALTH

COPD

Chronic obstructive pulmonary disease, a group of conditions that limit airflow.

04 / LUNG HEALTH

Emphysema

Damage to the lungs’ air sacs, and one of the main forms of COPD.

05 / LUNG HEALTH

Pulmonary Fibrosis

Scarring of lung tissue that can make breathing more difficult.

These are educational consultation topics, not confirmed indications for stem cell or exosome products. Listing a condition does not establish treatment benefit or confirm services available at TNC. Review the evidence, risks, regulatory status, and established care options with your specialist.
Start with your story

What to bring
to the conversation.

Share lung-function test results, imaging reports, current inhalers, oxygen needs, and any recent hospitalizations. Ask how any proposed option would relate to your ongoing pulmonary care.

Questions worth asking.

What is the exact product and intended use? What evidence supports inhalation for my diagnosis? How would my pulmonologist be involved, and what monitoring would be required?

Evidence & perspective

Understand what is known.

FDA warns that the regenerative products covered by its consumer alert are not approved for lung diseases such as COPD. No FDA-approved exosome products exist; inhalation does not establish safety or effectiveness.

These educational topics do not confirm treatment availability or establish candidacy. Ask a qualified provider to review the specific proposal.

View patient resources ↓
Your next step

Make room for your questions.

Contact your clinic about consultation availability, fees, and records to provide. Your next step may be further evaluation or a specialist referral.

Find your TNC clinic ↗
← Explore all categories
Patient resources

FDA: Stem cells and exosomes consumer alert ↗

Educational information reviewed October 29, 2026. Discuss your individual circumstances with a qualified provider.